These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 28277883)

  • 1. Prucalopride for the treatment of ileus.
    Smart CJ; Malik KI
    Expert Opin Investig Drugs; 2017 Apr; 26(4):489-493. PubMed ID: 28277883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of prucalopride on postoperative ileus in guinea pigs.
    Park SJ; Choi EJ; Yoon YH; Park H
    Yonsei Med J; 2013 Jul; 54(4):845-53. PubMed ID: 23709417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prucalopride and Bowel Function Post Gastrointestinal Surgery: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Talwar G; Sharma S; McKechnie T; Yang S; Khamar J; Hong D; Doumouras A; Eskicioglu C
    Am Surg; 2024 Jun; 90(6):1682-1701. PubMed ID: 38530772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative administration of the 5-HT4 receptor agonist prucalopride reduces intestinal inflammation and shortens postoperative ileus via cholinergic enteric neurons.
    Stakenborg N; Labeeuw E; Gomez-Pinilla PJ; De Schepper S; Aerts R; Goverse G; Farro G; Appeltans I; Meroni E; Stakenborg M; Viola MF; Gonzalez-Dominguez E; Bosmans G; Alpizar YA; Wolthuis A; D'Hoore A; Van Beek K; Verheijden S; Verhaegen M; Derua R; Waelkens E; Moretti M; Gotti C; Augustijns P; Talavera K; Vanden Berghe P; Matteoli G; Boeckxstaens GE
    Gut; 2019 Aug; 68(8):1406-1416. PubMed ID: 30472681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised clinical trial: prucalopride, a colonic pro-motility agent, reduces the duration of post-operative ileus after elective gastrointestinal surgery.
    Gong J; Xie Z; Zhang T; Gu L; Yao W; Guo Z; Li Y; Lu N; Zhu W; Li N; Li J
    Aliment Pharmacol Ther; 2016 Apr; 43(7):778-89. PubMed ID: 26880227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of prucalopride in adults with chronic idiopathic constipation.
    Vijayvargiya P; Camilleri M
    Expert Rev Clin Pharmacol; 2019 Jul; 12(7):579-589. PubMed ID: 31096799
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of prucalopride in adults and children with chronic constipation.
    Diederen K; Mugie SM; Benninga MA
    Expert Opin Pharmacother; 2015 Feb; 16(3):407-16. PubMed ID: 25539475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prucalopride succinate for the treatment of constipation: an update.
    Bassotti G; Gambaccini D; Bellini M
    Expert Rev Gastroenterol Hepatol; 2016; 10(3):291-300. PubMed ID: 26647167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
    Bassotti G; Usai Satta P; Bellini M
    Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prucalopride: For functional constipation only?
    Bellini M; Gambaccini D; Bassotti G
    Tech Coloproctol; 2016 Jul; 20(7):433-6. PubMed ID: 27174045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation.
    Tack J; Corsetti M
    Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1327-35. PubMed ID: 22985444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New therapeutic strategies for postoperative ileus.
    van Bree SH; Nemethova A; Cailotto C; Gomez-Pinilla PJ; Matteoli G; Boeckxstaens GE
    Nat Rev Gastroenterol Hepatol; 2012 Nov; 9(11):675-83. PubMed ID: 22801725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YH12852, a potent and highly selective 5-HT
    Hussain Z; Lee YJ; Yang H; Jeong EJ; Sim JY; Park H
    Neurogastroenterol Motil; 2017 Oct; 29(10):1-6. PubMed ID: 28516458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prucalopride in critically ill patients with paralytic ileus: A pilot randomized double-blind placebo-controlled trial.
    Jandee S; Wetwittayakhlang P; Boonsri P
    J Gastroenterol Hepatol; 2021 Feb; 36(2):362-366. PubMed ID: 32483847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of prucalopride on esophageal secondary peristalsis in reflux patients with ineffective motility.
    Lei WY; Hung JS; Liu TT; Yi CH; Chen CL
    J Gastroenterol Hepatol; 2018 Mar; 33(3):650-655. PubMed ID: 28898473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prucalopride to improve time to gut function recovery following elective colorectal surgery: randomized clinical trial.
    Milne T; Liu C; O'Grady G; Woodfield J; Bissett I
    Br J Surg; 2022 Jul; 109(8):704-710. PubMed ID: 35639621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prucalopride: A Review in Chronic Idiopathic Constipation.
    Garnock-Jones KP
    Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral prucalopride in children with functional constipation.
    Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
    J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prucalopride: a review of its use in the management of chronic constipation.
    Keating GM
    Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
    Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
    Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.